Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

When it comes to selecting Cabinet members for President-elect Donald Trump's second term, you can't have too much of a good thing.

Cartesian Therapeutics, Inc. ( ($RNAC) ) has released its Q3 earnings. Here is a breakdown of the information Cartesian ...

As the president who oversaw the COVID-19 response—which public-health experts say was lacking in many ways, aside from the ...

PHILADELPHIA — The same technology that saved millions of lives during the COVID-19 pandemic appears to hold promise against another scourge of infectious disease, according to new research from the ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have made a major discovery in how human ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molina Healthcare (MOH – Research Report), ...

WASHINGTON — If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s ...